ABSTRACT
INTRODUCTION
Glutamine (Gln) is the most abundant free amino acid in plasma and muscle and is an integral substrate in numerous metabolic function. 1, 2 A variety of animal and human trials have been published demonstrating that Gln has immunoenhancing properties (3) (4) (5) (6) . Previous reports have revealed that a relative Gln deficiency state has been created by the catabolic process, and Gln supplementation have corrected the nutritional deficiency and hence improved outcome. Gln is required during a catabolic process to manifest optimal tissue responses to catabolism, inflammation and infection (7) .
Sepsis is a cause of death in patients with major surgery. Sepsis is initiated by bacteria and their related toxins. When bacterial toxins insult the body, profound alterations in both immune responses and organ functions may occur. 8 Studies showed that during inflammatory states such as sepsis and injury, the consumption of Gln by circulating and immunologic cell increases (9) (10) (11) . Gln is an important fuel for lymphocytes and macrophages (12) . Studies revealed that supplemental Gln augments the in vitro bactericidal activity of neutrophils in burned or postoperative patients (13) (14) . Parry-Billings et al. 12 reported that depressed Gln concentrations were associated with reduced phagocytosis by peritoneal macrophages in normal mice.
An in vitro study by Wallace and Keast 15 showed that Gln is required for phagocytosis of opsonized sheep erythrocytes in macrophage culture. In an in vivo study, a
Gln-enriched diet significantly increased superoxide production, and Candida albicans killing by peritoneal macrophage (16) . Phagocytic cells are an essential arm of the host defense against microbes. Macrophages and neutrophils are involved in the early, nonspecific host-defense responses and play an important role in the pathophysiology and/or protection against sepsis. 17, 18 Most of the reports demonstrated that Gln augments phagocytosis were in vitro studies, and samples used for evaluating the effect of Gln were derived from healthy or conditions other than sepsis. To our knowledge, the effects of Gln on phagocytic activity in gut-origin sepsis have not been previously studied. Therefore, our aim was to investigate the effect of Gln supplementation before and after sepsis and both before and after on the ability of the host defense to kill translocated enteric bacteria in the peritoneal cavity and organisms that invade the systemic circulation. Also, the distribution of systemic lymphocyte subpopulations were analyzed to investigate the effect of Gln on the phenotype of blood lymphocytes in septic rats.
MATERIALS AND METHODS

Animals
Male Wistar rats aged 8 wk and weighing 200-230 g were used in this study. All rats were housed in temperature-and humidity-controlled rooms and were allowed free access to a standard rat chow for 1 wk prior to the experiment. The care of the animals followed the guidelines for the care and use of laboratory animals established by the Animal Care Committee of the Taiwan University Hospital, and protocols were approved by that committee.
Study protocol
All rats were randomly assigned to the control and 4 experimental groups. The control group and experimental groups 1 and 2 were fed a common semipurified diet.
Rats in the experimental groups 3 and 4 were fed an identical diet except that part of the casein was replaced by Gln, which provided 25% of nitrogen (Table 1) . After feeding rats the respective diets for 10 days, sepsis in the experimental groups was induced by CLP, whereas the control group underwent sham operation. CLP was performed according to the method of Wichterman et al. 19 Briefly, rats were anesthetized with intraperitoneal pentobarbital (50 mg/kg), and the abdomen was opened through a midline incision. The cecum was isolated, and a 3-0 silk ligature was placed around it, ligating the cecum just below the ileocecal valve. The cecum was then punctured twice with an 18-gauge needle and was replaced back into the were supplemented with Gln, which replaced 25% of total amino acid nitrogen in the TPN solution. TPN provided 280 kcal/kg body weight, and the kcal/nitrogen ratio was 120:1. The TPN solutions were isonitrogenous and identical in nutrient composition except for the difference in the amino acid content ( Table 2 ). There were 5 groups in this study: normal control group, Gln was not supplemented before and after sham operation; group 1, Gln was not supplemented before and after CLP (-/-); group 2, semipurified diet before and Gln-containing TPN after CLP (-/+); group 3, Gln-enriched diet before and conventional TPN after CLP (+/-); and group 4, Gln-enriched diet before and Gln-containing TPN after CLP (+/+).
Measurements and analytical procedures
TPN was continued until the time of sacrifice at day 3 after CLP and surviving rats were weighed and anesthetized. A middle abdominal incision was made, and 10 ml of phosphate-buffered saline (PBS) was intraperitoneally injected to elute the peritoneal cells. After harvesting the peritoneal lavage fluid (PLF), the rats were sacrificed by drawing arterial blood from the aorta of the abdomen. Fresh PLF was used for macrophage cell counts and phagocytic activity analysis. Blood samples were collected in tubes containing heparin. Whole blood was used for analyzing lymphocyte subpopulation distribution and neutrophil phagocytosis. Plasma was centrifuged from the remaining blood, and was stored at -80℃ for analysis of amino acid concentrations.
Plasma amino acid analysis
Plasma amino acids were analyzed by standard ninhydrin technology (Beckman Instruments, model 6300, Palo Alto, CA), after deproteinization of the plasma with 5% salicylic acid. 20 
Lymphocytes subpopulation distribution
Flow cytometry was used to determine the proportions of CD45Ra, CD3, CD4, and 
Phagocytosis assay of blood polymorphonuclear neutrophils (PMNs):
21,22
A flow cytometric phagocytosis test was used to evaluate the phagocytic 
Quantitative and phagocytosis assay of peritoneal macrophages
Peritoneal macrophages were centrifuged from PLF. The pallets were washed 3 times with HBSS. After dilution with equal volume of Turk's solution, the cell concentration was counted. The cell number was adjusted to 10 6 cells/ml with RPMI-1640 supplemented with 5% fetal bovine serum and an adequate amount of antibiotics. After distributing 100 μl of diluted solutions into each well on a 96-well microplates it was transferred to a 37 ℃ CO 2 incubator for 1 h to allow the cells to adhere to the microplate surface. A Vybrant TM Phagocytosis Assay kit (Molecular Probes) was used to evaluate the phagocytic activity of peritoneal macrophages. The RPMI solution was removed from all microplate wells by vacuum aspiration, and then 100 μl of the prepared FITC-labeled E. coli was added to each well for 2 h. Labeled bacteria were removed by vacuum aspiration, and 100 μl of trypan blue suspension was added to all wells within 1 min. The excess trypan blue was immediately aspirated, and the experimental and control wells (without peritoneal macrophages)
were read in the fluorescence plate reader using ~480 nm for excitation and ~520 nm for emission.
In vitro cultures of splenocytes. Splenocytes were obtained by mechanical disruption of the spleen with a spatula on a stainless mesh. Cell suspensions were passed through a sterile nylon mesh to remove debris. RBCs were lysed by sterile distilled water for 15 s, and immediately neutralized to isotonic cell suspensions.
After washing with PBS 3 times (300 xg for 5 min), splenocytes were resuspended in RPMI-1640 with antibiotics and fetal calf serum. The number of isolated splenocytes was determined by a hemacytometer count using the trypan blue dye exclusion method.
Cytokine assay. Phytohemagglutinin (PHA, 200 ng/mL; Sigma) were used to stimulate cytokine production by isolated splenocytes lymphocytes in culture. 
Statistical Analysis
Data are expressed as the mean ± SD. Differences among groups were analyzed by two-way ANOVA using Fisher's test. A p value of < 0.05 was considered statistically significant.
RESULTS
There were no differences in initial body weights and body weights after feeding the experimental diets for 10 days, and after TPN administration for 3 days among the 5 groups (data not shown). The Gln-supplemented groups (group 2, 498.0 ± 50.4; group 3, 473.1 ± 50.1; group 4, 481.7 ± 55.0 nmol/mL) had significantly higher plasma Gln levels than did group 1 (378.9 ± 42.9 nmol/mL), and had no differences from the control group (483.9 ± 61.5 nmol/mL). Groups 1 and 3 had higher peritoneal macrophage numbers than the control group. The cell numbers of peritoneal macrophage were comparable among groups 2, 4 and the control group (Fig 1) . Phagocytic activities were significantly higher in groups 3 (+/-) and 4 (+/+) than in the control group and groups 1 (-/-), whereas there were no differences among group 2 and the control group. There were no differences in the phagocytic activities of blood PMNs among all groups (Fig 2) .
The distributions of CD3+ in the group 1 (-/-) were significantly lower than the control group, whereas no differences were observed among the control and Gln supplemented groups. CD4+ distribution was significantly lower in the group 1 compared with the control or groups 3 and 4. There were no differences in the distributions of blood CD8+ cells among the all groups. The group 4 had higher CD45Ra+ distribution than the control group. No differences were observed in CD45Ra+ distribution among the control and the experimental groups except group 4 (Fig 3) .
There were no differences in the IL-2, IL-10 and IFN-γ levels among the 5 groups, and IL-4 was not detectable when splenocytes were stimulated with mitogen (Fig 4) .
The survival rates were higher in the control group (100%) than the experimental groups. No differences in survival rates were observed among the 4 experimental 
DISCUSSION
In this study, 25% of total nitrogen in the TPN solution was supplied by Gln.
This amount of Gln was previously found to enhance the immune response in rodents. 23, 24 We provided oral Gln supplementation for 10 days before sepsis induction. This model mimics the septic complications in patients with abdominal surgery, in whom preventive use of a Gln-supplemented enteral diet may be recommended. TPN was administered after CLP, because sepsis has been shown to cause histologic damage, and adversely affect the barrier and metabolic functions of the small intestine 25, 26 A study by Gardiner et al. 27 showed that sepsis induced by CLP resulted in impaired intestinal amino acid uptake, and the parenteral rather than the enteral route of Gln therapy may have benefits for survival from septic insult. We used CLP as a sepsis model, because CLP is clinically relevant and is considered to be a simple and reproducible model of gut-derived sepsis in rats (19) .
Results of phagocytic activity of peritoneal macrophages showed that Glnenriched diet before sepsis had beneficial effects on enhancing phagocytic activity.
Gln administered both before and after CLP seemed to have a synergistic effect on phagocytic activity. A study by Furukawa et al (14) demonstrated that Gln-enriched enteral diet enhances bacterial clearance in a bacterial peritonitis model, possibly by promoting peritoneal macrophage phagocytosis. We observed that the enhancing effect of peritoneal phagocytosis was not obvious when Gln was administered intravenously after CLP. This finding may indicate that although parenteral Gln infusion maintained plasma Gln levels after CLP, the effect of Gln on phagocytic activity of peritoneal macrophages is limited. PMNs are potent inflammatory cells, and both the total number and percentage of circulating PMNs can be induced by acute infection and endotoxin. 18 PMNs efficiently engulf a wide variety of microbes.
In this study, the phagocytic activity of blood PMNs cells did not differ among the all groups. Since the peritoneal cavity is the primary site of injury, it is possible that Gln augments phagocytic activity at the location of bacterial invasion. The effect of Gln on phagocytic cells in the systemic circulation was not obvious. indicate that Gln had no effect on modulating the production of the cytokines under the present experimental condition. This result was consistent with the report by Kew et al (23) that Gln supplementation did not influence IL-4, IL-10, and IFN-γ production by spleen lymphocytes. However, study by Kew et al (23) showed that IL-2 production was increased in spenocytes when Gln was administered. Also, an in vitro study by Rohde et al (31) showed that Gln enhanced the production of IL-2 and IFN-γ by blood mononuclear cells. Since the samples used for evaluating the effect of Gln on cytokine production were derived from healthy volunteers and normal mice, response to the stressed metabolic condition observed in this study may differ, and may consequently lead to different immune responses. Considering that the in vitro splenocyte stimulation may not totally reflect actual in vivo situations, quantitation of cytokine mRNA expression in spleen is now under investigation in our laboratory.
In summary, this study shows that enteral Gln-enriched diets before CLP significantly enhances peritoneal macrophage phagocytic activity, preserved CD4+ cells and maintained blood total T lymphocytes. Gln administered both before and after CLP seemed to have a synergistic effect on enhancing peritoneal macrophage phagocytic activity and systemic B cell distribution. However, Gln administration had no favorable effects on systemic phagocytic activity and the production of T cell -derived cytokine in spenocytes. Also, no survival benefit was observed in Gln supplemented rats with gut-derived sepsis. It is possible that Gln predominantly augments the immune response in the location of injurious stimulus, the effect of Gln on systemic immune response may not potent enough to evoke a survival benefit under the present experimental condition. Since survival was only noted for 3 days, whether Gln supplementation may improve survival over a longer period required further investigation. were significant higher than those of groups 1 (-/-) and 2 (-/+) (p < 0.05). (group 1, n = 8; group 2, n = 11; group 3, n =9; group 4, n = 9). hours (group 1, n = 8; group 2, n = 11; group 3, n =9; group 4, n = 9).. 
